(4aS,5aR)-N-[1-[(R)-[(2R)-1,1-dioxothian-2-yl]-phenylmethyl]pyrazol-4-yl]-5,5-difluoro-5a-methyl-1,4,4a,6-tetrahydrocyclopropa[f]indazole-3-carboxamide
| 中文名称 | (4aS,5aR)-N-[1-[(R)-[(2R)-1,1-dioxothian-2-yl]-phenylmethyl]pyrazol-4-yl]-5,5-difluoro-5a-methyl-1,4,4a,6-tetrahydrocyclopropa[f]indazole-3-carboxamide |
|---|---|
| 中文同义词 | 化合物 T15402;化合物 GNE-4997 |
| 英文名称 | (4aS,5aR)-N-[1-[(R)-[(2R)-1,1-dioxothian-2-yl]-phenylmethyl]pyrazol-4-yl]-5,5-difluoro-5a-methyl-1,4,4a,6-tetrahydrocyclopropa[f]indazole-3-carboxamide |
| 英文同义词 | (4aS,5aR)-N-[1-[(R)-[(2R)-1,1-dioxothian-2-yl]-phenylmethyl]pyrazol-4-yl]-5,5-difluoro-5a-methyl-1,4,4a,6-tetrahydrocyclopropa[f]indazole-3-carboxamide;GNE-4997;GNE 4997,GNE4997;Cycloprop[f]indazole-3-carboxamide, 5,5-difluoro-1,4,4a,5,5a,6-hexahydro-5a-methyl-N-[1-[(R)-phenyl[(2R)-tetrahydro-1,1-dioxido-2H-thiopyran-2-yl]methyl]-1H-pyrazol-4-yl]-, (4aS,5aR)- |
| CAS号 | 1705602-02-3 |
| 分子式 | C25H27F2N5O3S |
| 分子量 | 515.58 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 1705602-02-3.mol |
| 结构式 | ![(4aS,5aR)-N-[1-[(R)-[(2R)-1,1-dioxothian-2-yl]-phenylmethyl]pyrazol-4-yl]-5,5-difluoro-5a-methyl-1,4,4a,6-tetrahydrocyclopropa[f]indazole-3-carboxamide 结构式](CAS/20210305/GIF/1705602-02-3.gif) |
(4aS,5aR)-N-[1-[(R)-[(2R)-1,1-dioxothian-2-yl]-phenylmethyl]pyrazol-4-yl]-5,5-difluoro-5a-methyl-1,4,4a,6-tetrahydrocyclopropa[f]indazole-3-carboxamide 性质
| 沸点 | 727.0±60.0 °C(Predicted) |
|---|---|
| 密度 | 1.58±0.1 g/cm3(Predicted) |
| 储存条件 | Store at -20°C |
| 溶解度 | 溶于二甲基亚砜 |
| 酸度系数(pKa) | 11.35±0.60(Predicted) |
(4aS,5aR)-N-[1-[(R)-[(2R)-1,1-dioxothian-2-yl]-phenylmethyl]pyrazol-4-yl]-5,5-difluoro-5a-methyl-1,4,4a,6-tetrahydrocyclopropa[f]indazole-3-carboxamide 用途与合成方法
GNE-4997 是一种有效选择性的白细胞介素 2 诱导的 T 细胞激酶 (ITK) 抑制剂，Ki 为 0.09 nM，GNE-4997 中可溶性元素碱度与靶外抗增殖作用的相关性降低了细胞毒性。